MAC
65
3
UNP
50
2
AMZN
53
3
BDX
63
8
NTRS
65
5
SYF
86
3
EMC
69
2
SLG
35
-7
PGR
49
-3
SWK
64
8
NWS
46
2
LH
50
2
HPE
68
2
PX
60
7
EOG
54
4
GRMN
50
7
AVGO
40
5
FTI
78
9
SHW
52
2
TRV
50
-2
MAC
65
3
UNP
50
2
AMZN
53
3
BDX
63
8
NTRS
65
5
SYF
86
3
EMC
69
2
SLG
35
-7
PGR
49
-3
SWK
64
8
NWS
46
2
LH
50
2
HPE
68
2
PX
60
7
EOG
54
4
GRMN
50
7
AVGO
40
5
FTI
78
9
SHW
52
2
TRV
50
-2
Financhill
Back

Direxion Daily S&P Biotech Bull 3X Shares Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Sell
47

LABU
Direxion Daily S&P Biotech Bull 3X Shares

Last Price:
$166.04
Seasonality Move:
-4.1%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$88.79
Seasonality Move:
10.35%
Sell
47
Direxion Daily S&P Biotech Bull 3X Shares (LABU) is a Sell

Is Direxion Daily S&P Biotech Bull 3X Shares a Buy, Sell or Hold?

  • The current Direxion Daily S&P Biotech Bull 3X Shares [LABU] share price is $160.74. The Score for LABU is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • LABU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $89.89. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

LABU Stock Price Chart

What is Direxion Daily S&P Biotech Bull 3X Shares's stock price today?

  • The Direxion Daily S&P Biotech Bull 3X Shares share price today is $160.74
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LABU is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $89.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

LABU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.81 Buy
Relative Strength Index (14 RSI): 60.96 Buy
Chaikin Money Flow: 250229 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (127.72 - 161.4) Buy
Bollinger Bands (100): (68.13 - 133.55) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.97 Buy
Relative Strength Index (14 RSI): 74.6 Buy
Chaikin Money Flow: -245448 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.76 - 76.32) Buy
Bollinger Bands (100): (43.16 - 65.2) Buy

LABU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 160.06 Buy
20-day SMA: 150.19 Buy
50-day SMA: 129.59 Buy
200-day SMA: 80.53 Buy
8-day EMA: 160.13 Buy
20-day EMA: 151.02 Buy
50-day EMA: 129.92 Buy
200-day EMA: 68.08 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.13 Buy
20-day SMA: 69.22 Buy
50-day SMA: 63.2 Buy
200-day SMA: 44.78 Buy
8-day EMA: 78.76 Buy
20-day EMA: 71.36 Buy
50-day EMA: 63.96 Buy
200-day EMA: 50.19 Buy

Direxion Daily S&P Biotech Bull 3X Shares Earnings Growth & LABU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.35 per share.

Direxion Daily S&P Biotech Bull 3X Shares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):